Search Results: lung cancer (115)

Roche reports positive five-year survival outcomes for extensive-stage small cell lung cancer

By 0
IMbrella A, an extension of the Phase III IMpower133 study, demonstrates the potential for a durable overall survival benefit with Tecentriq plus chemotherapy in extensive-stage small cell lung cancer (ES-SCLC)
IMbrella A data build on the previously reported IMpower133 trial, which was the first clinically meaningful advance in the treatment of ES-SCLC in more than twenty years

Log In or Register as a healthcare professional to read the full article.

Evolving Paradigms in Triple-Negative Breast Cancer Treatment: From Standard Chemotherapy to Targeted Therapies

By 0
From biomarker-driven therapies to antibody-drug conjugates, new treatments are offering more personalised and effective options for triple negative breast cancer (TNBC), an aggressive subtype of breast cancer. These innovations are helping improve survival rates and transforming how TNBC is managed, but they also come with unique challenges that require careful clinical consideration.

Log In or Register as a healthcare professional to read the full article.

Press Release – Roche’s Tecentriq® SC (atezolizumab) becomes the first subcutaneous anti-PD-(L)1 cancer immunotherapy available to patients in Singapore, reducing treatment time to a few minutes

By 0
Roche announced today that Tecentriq® SC (atezolizumab) has been approved by the Singapore Health Sciences Authority (HSA) for all indications in which the intravenous (IV) formulation of Tecentriq has been previously approved, including certain types of lung, breast and liver cancer.4 Tecentriq SC is Roche’s fourth subcutaneous cancer therapy,5-7 and the world’s first injectable anti-PD-(L)1 cancer immunotherapy.

Log In or Register as a healthcare professional to read the full article.

Western Visayas Medical Center (WVMC) Heart and Lung Building: A Beacon of Excellence in Cardiovascular and Pulmonary Care

By 0

In a momentous occasion, the Western Visayas Medical Center (WVMC) unveiled its Heart and Lung building, marking a significant leap forward in the region’s healthcare landscape. Nestled in the heart of Western Visayas, this state-of-the-art facility stands as a beacon of excellence, offering comprehensive cardiovascular and pulmonary care services to patients across the region.